Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |

Search | Disclaimer | Accessibility | Rule 26 | Site map |

Minster Pharmaceuticals

Investor relations

Rule 26Reports & presentationsShare priceMajor shareholdersAdvisorsCorporate governance
Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules (February 2007) and has been updated to 28 August 2008:

 

Company Information
Description of the business
Directors' names, biographies and responsibilities
Board committees
Country
The country of incorporation and main country of operations is England.
Details of the NOMAD and key Company advisers




Documents and announcements
The most recent annual report and accounts
Interim reports published since the last annual report
 
All announcements made to a regulatory information service within the last twelve months


 

Securities Information
Any publications or communications sent to shareholders within the last 12 months
Details of other current and future exchanges and platforms on which securities are traded
The Company has not applied or agreed to have any of its securities (including its AIM securities) admitted to or traded on any other exchanges or trading platforms
Current constitutional documents
Number of AIM securities in issue